Trial Profile
A 4 week, parallel-design, double-blind, placebo-controlled trial of gabapentin in the treatment of neuroleptic-induced tremor: Clinical and instrumental ratings of outcome
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Oct 2007
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Tremor
- Focus Therapeutic Use
- 06 Oct 2007 New trial record.